TRENDING : Top 50   TVIX (0%)    VXX (0%)    EEM (0%)    GM (0%)    MA (0%)    SPY (0%)    XLY (0%)    AMZN (0%)    BTCUSD (%)    CLBS (0%)    ABMD (0%)    AAPL (0%)    FB (0%)    GEVO (0%)    GS (0%)    IPGP (0%)    JD (0%)    NFLX (0%)    PEP (0%)    SEDG (0%)    SPX (0%)    EWI (0%)    CBIO (0%)    CARA (0%)    CANF (0%)

BIIB - Biogen Inc.

$296.00 (-0.46%)




RECENT SUCCESSFUL RECOMMENDATIONS

No recommendations found.

RECENT RECOMMENDATIONS

Stocks

No recommendations found.

Options

No recommendations found.


** Recommendations from last 7 days only. Subscribe to different services to see past recommendations

TRENDING ARTICLES



First Week of August 17th Options Trading For Biogen (BIIB)

NASDAQ NEWS   -  6/20/2018

Don't Get Too Excited About PTC Therapeutics (Yet)

NASDAQ NEWS   -  6/20/2018

Commit To Purchase Biogen At $195, Earn 3.4% Using Options

NASDAQ NEWS   -  6/19/2018

PTC Therapeutics' Spinal Muscular Atrophy Study Successful

NASDAQ NEWS   -  6/19/2018

Why Biogen, Baytex Energy, and Catalyst Biosciences Slumped Today

NASDAQ NEWS   -  6/18/2018

Monday Sector Laggards: Consumer Products, Healthcare

NASDAQ NEWS   -  6/18/2018

Market Close Report: NASDAQ Composite index closes at 7,747.03 up .65 points

NASDAQ NEWS   -  6/18/2018

Monday's ETF with Unusual Volume: IXJ

NASDAQ NEWS   -  6/18/2018

Here's Why PTC Therapeutics Is Soaring While Biogen and Ionis Struggle

NASDAQ NEWS   -  6/18/2018

Notable Monday Option Activity: FB, BIIB, GWW

NASDAQ NEWS   -  6/18/2018

Nasdaq 100 Movers: BIIB, JD

NASDAQ NEWS   -  6/18/2018

Validea's Top Five Healthcare Stocks Based On Warren Buffett - 6/17/2018

NASDAQ NEWS   -  6/17/2018

Validea's Top Five Healthcare Stocks Based On Peter Lynch - 6/17/2018

NASDAQ NEWS   -  6/17/2018

Validea's Top Five Healthcare Stocks Based On John Neff - 6/17/2018

NASDAQ NEWS   -  6/17/2018

Roche Announces Positive Data on Gazyva and MS Drug Ocrevus

NASDAQ NEWS   -  6/15/2018

Biogen Reaches Option Agreement To Buy TMS' Phase 2 Asset For Acute Stroke

NASDAQ NEWS   -  6/7/2018

Alkermes Receives License Payment From Biogen - Quick Facts

NASDAQ NEWS   -  6/6/2018

BIIB's Alzheimer's Drug Scores Well, EXAS Heads Higher, VXRT Down But Not Out

NASDAQ NEWS   -  6/6/2018

FWP Back In News, ARCT Gearing Up For The Big Day, All Eyes On QTNT

NASDAQ NEWS   -  5/22/2018

Biogen To Reduce Royalty Rates On Aducanumab; To Pay $50 Mln To Neurimmune

NASDAQ NEWS   -  5/1/2018

Biogen Q1 18 Earnings Conference Call At 8:30 AM ET

NASDAQ NEWS   -  4/24/2018